Whitebox Advisors’s Intelligent Medicine Acquisition Corp. Warrant IQMDW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$4.6K 573
2023
Q1
$4.6K Hold
100,000
﹤0.01% 429
2022
Q4
$1.07K Hold
100,000
﹤0.01% 690
2022
Q3
$9K Hold
100,000
﹤0.01% 659
2022
Q2
$13K Hold
100,000
﹤0.01% 630
2022
Q1
$28K Buy
+100,000
New +$36.5K ﹤0.01% 657

Whitebox Advisors's IQMDW Position: Q2 2023 in Review

Whitebox Advisors sold out of Intelligent Medicine Acquisition Corp. Warrant (IQMDW) in Q2 2023, closing a stake of 100,000 shares — an estimated $4.6K sold.

Whitebox Advisors first reported a position in IQMDW in Q1 2022 and held it in 5 quarters. The position peaked at $28K in Q1 2022. 0 funds tracked by Wall St. Rank hold IQMDW as of Q2 2023.

  • Whitebox Advisors reported no remaining Intelligent Medicine Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
  • Whitebox Advisors sold 100,000 Intelligent Medicine Acquisition Corp. Warrant shares in Q2 2023, an estimated $4.6K.
  • Whitebox Advisors first reported a position in Intelligent Medicine Acquisition Corp. Warrant in Q1 2022 and held it in 5 quarters.
  • Whitebox Advisors's Intelligent Medicine Acquisition Corp. Warrant position peaked at $28K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Warrant as of Q2 2023.

Based on Whitebox Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.